XDH and coronary artery disorder: Reports on the potential effects of the XOR inhibitor, allopurinol, in reducing cardiovascular events in patients with hypertension and reduced kidney function [58] or an increase in systemic XO activity in patients with coronary artery disease [60] support the idea that XOR inhibitors may also reduce oxidative stress and play an important therapeutic role [61].